Preparing for market
We understand the need for service integration when taking a product to market. During this phase (typically clinical phases II and III) our outcomes research and Health Economics consultants will integrate closely with your HEOR, marketing and trial teams to address market access objectives. Oxford Outcomes has deep experience of providing scientific and strategic services that support clinical trials, as well as preparing for strategic market access.
Our key services are:
- Strategic Market Access strategies.
- Economic modeling: cost effectiveness, burden of illness, budget impact.
- Reimbursement landscape assessments.
- Selection, development and validation of PRO and ePRO measures.
- Evidence synthesis including Meta analysis and indirect comparison.
- Utilities elicitation and patient preference studies.
- Quantitative and qualitative PRO research.
- Translation and Linguistic Validation of PRO measures.
- Medical translations.
- Advocacy relations
- Safety and risk benefit analysis.
- Patient registry studies.
- Market research.
- Evidence dossiers.
For more information regarding services in this stage please contact oxford@oxfordoutcomes.com